15 January 2015 - Deborah Wilkes
Archived
The risk of allergic reactions to medicines containing ambroxol or bromhexine is "small", the European Union's Pharmacovigilance Risk Assessment Committee (PRAC) has concluded following a safety review.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.